Navigation Links
Frozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I from BioChain

ProductsFrozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I from BioChain
Company BioChain
Item Frozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I
Price $375.00
Description 8 different frozen tissues are mounted on positively charged glass slides
Info BioChainBioChain
BioChain Institute, Inc.
3517 Breakwater Avenue
Hayward, CA 94545 USA



Call BioChain to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-510-342-5324
Customer Service: 510.783.8588
Fax Number: 510.783.5386
Web Site: http://www.biochain.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Frozen-EZ Yeast Transformation II Kit from Zymo Research
2. Mouse Frozen Reproductive Tissue Microarray from Zyagen Laboratories
3. Mouse Frozen Mixed Tissue Microarray, Panel -3 from Zyagen Laboratories
4. Mouse Frozen Neuronal Tissue Microarray from Zyagen Laboratories
5. Mouse Frozen Digestive Tissue Microarray from Zyagen Laboratories
6. Rat Frozen Reproductive Tissue Microarray from Zyagen Laboratories
7. Rat Frozen Neuronal Tissue Microarray from Zyagen Laboratories
8. Rat Frozen Mixed Tissue Microarray, Panel- 2 from Zyagen Laboratories
9. Sf9 Frozen Cells (Graces Media) from Invitrogen
10. Sf21 Frozen Cells (Graces Media) from Invitrogen
11. Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue I from BioChain
... Immunogen: KLH-conjugated, synthetic ... in which [ Ac K] corresponds to ... Accession Number: NM_003493 ... ~17kDa Quality Assurance: ...
... is used to detect the appearance of ... infected cells as early as 8-24 hours ... FastPlax Titer Kit, which allows determination of ... The FastPlax Antibody can also be ...
Anti-Mouse Ly 6C.2 , Ascites (Clone 5075-3.6) (mouse IgG2b)...
b-Catenin (pSer675), phospho-specific...
Biology Products:
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a ... announced that its DigitalPersona ® Pro Enterprise ... have been deployed throughout First Bank branch locations ... South Carolina and Virginia. First Bank, ... Southern Pines, North Carolina , selected ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... inferences about the intentions of other individuals in order ... of everyday life that we humans take for granted. ... Max Planck Institute in Germany, this ability is present ... in the April issue of Current Directions in Psychological ...
... the National Institute on Drug Abuse (NIDA), part of ... time identified genes that might increase a person’s ability ... by Dr. George Uhl at NIDA’s Intramural Research Program ... the Center for Nicotine and Smoking Cessation Research at ...
... international team of 19 researchers calls for better forecasting ... The researchers, led by Daniel B. Botkin, note that ... be at risk from global warming, surprisingly few species ... period encompassing several ice ages. They suggest that this ...
Cached Biology News:Man's best friend lends insight into human evolution 2NIDA study identifies genes that might help some people abstain from smoking 2
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
(Date:12/15/2014)... Dec. 15, 2014  Ascendis Pharma A/S, a ... to address significant unmet medical needs, today announced ... 2 pediatric study to evaluate once-weekly TransCon Growth ... GHD.  This interim analysis consists of 25 patients, ... in the study, completing all six months of ...
(Date:12/13/2014)... 12, 2014 Clarassance, a privately held ... new name: Therabron Therapeutics , Inc. The new ... (a type of structure in the lungs similar to ... to develop novel protein therapeutics for the treatment of ... to change the name to mark the company's escalation ...
Breaking Biology Technology:Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2